Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Ecopetrol
EC
$34.5B
| $3.45M | ﹤0.01% |
337,023
+10,736
| +3% | +$108K |
|
2377
IDEAYA Biosciences
IDYA
$3.42B
| $3.43M | ﹤0.01% |
146,116
+26,913
| +23% | +$553K |
|
2378
Tootsie Roll Industries
TR
$2.93B
| $3.43M | ﹤0.01% |
105,779
-39,939
| -27% | -$1.46M |
|
2379
QuinStreet
QNST
$890M
| $3.42M | ﹤0.01% |
387,787
+7,672
| +2% | +$77.4K |
|
2380
Seres Therapeutics
MCRB
$46.8M
| $3.42M | ﹤0.01% |
35,713
+4,020
| +13% | +$437K |
|
|
OPTU
2381
Optimum Communications Inc
OPTU
$298M
| $3.41M | ﹤0.01% |
1,128,244
-14,301
| -1% | -$40.6K |
|
2382
Definitive Healthcare
DH
$72M
| $3.4M | ﹤0.01% |
308,926
+106,827
| +53% | +$1.1M |
|
|
CTLP
2383
DELISTED
Cantaloupe
CTLP
| $3.37M | ﹤0.01% |
423,030
+7,074
| +2% | +$45.8K |
|
|
INST
2384
DELISTED
Instructure Holdings, Inc.
INST
| $3.35M | ﹤0.01% |
132,962
+5,743
| +5% | +$144K |
|
2385
indie Semiconductor
INDI
$682M
| $3.34M | ﹤0.01% |
355,324
+83,685
| +31% | +$756K |
|
|
DM
2386
DELISTED
Desktop Metal, Inc.
DM
| $3.33M | ﹤0.01% |
188,309
+17,468
| +10% | +$350K |
|
|
SLRN
2387
DELISTED
ACELYRIN
SLRN
| $3.33M | ﹤0.01% |
+159,248
| New | +$3.26M |
|
2388
Camden National
CAC
$978M
| $3.32M | ﹤0.01% |
107,137
+71
| +0.1% | +$2.27K |
|
|
SRDX
2389
DELISTED
Surmodics
SRDX
| $3.32M | ﹤0.01% |
105,948
+2,818
| +3% | +$64.3K |
|
|
NXDR
2390
Nextdoor Holdings
NXDR
$847M
| $3.31M | ﹤0.01% |
1,016,830
+351,465
| +53% | +$872K |
|
2391
Allogene Therapeutics
ALLO
$649M
| $3.31M | ﹤0.01% |
665,331
+15,046
| +2% | +$81.4K |
|
|
BASE
2392
DELISTED
Couchbase
BASE
| $3.28M | ﹤0.01% |
207,573
+15,215
| +8% | +$249K |
|
2393
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $3.27M | ﹤0.01% |
222,750
-20,667
| -8% | -$327K |
|
2394
Bally's
BALY
$682M
| $3.27M | ﹤0.01% |
209,858
-13,164
| -6% | -$212K |
|
2395
Enanta Pharmaceuticals
ENTA
$366M
| $3.25M | ﹤0.01% |
151,657
+3,099
| +2% | +$91.4K |
|
2396
United States Lime & Minerals
USLM
$3.16B
| $3.23M | ﹤0.01% |
77,420
+2,885
| +4% | +$101K |
|
2397
First Mid Bancshares
FMBH
$1.39B
| $3.23M | ﹤0.01% |
133,741
+2,173
| +2% | +$54.2K |
|
2398
Phibro Animal Health
PAHC
$1.47B
| $3.22M | ﹤0.01% |
235,035
-61,380
| -21% | -$879K |
|
2399
Dyne Therapeutics
DYN
$4.7B
| $3.21M | ﹤0.01% |
285,121
+57,537
| +25% | +$679K |
|
2400
iQIYI
IQ
$1.23B
| $3.21M | ﹤0.01% |
600,561
-8,477
| -1% | -$47.7K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.